Levothyroxine Sodium
Product Images NDC 10544-257

3 FDA label images from Blenheim Pharmacal, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 10544-257). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0.05mg 30ct (Label Levothyroxine Sodium Tabs 0 05mg Bpi(10544 256 30) Lannett(0527 1342 01) Rev2)

0.05mg 30ct (Label Levothyroxine Sodium Tabs 0 05mg Bpi(10544 256 30) Lannett(0527 1342 01) Rev2)
Label for Levothyroxine Sodium Tablets USP 50 mcg (0.05 mg), containing 30 tablets. The label shows the NDC number 10544-256-30 and manufacturer code 0527-1342-01. It includes storage instructions to keep the product at controlled room temperature and in a tight, light-resistant container. The label also indicates the product is prescription only and advises users to see the package insert for dosage information. The labeler is Blenheim Pharmacal, Inc.*
FDA Label Image

0.075mg 30ct (Label Levothyroxine Sodium Tabs 0 075mg Bpi(10544 257 30) Lannett(0527 1343 01) Rev2)

0.075mg 30ct (Label Levothyroxine Sodium Tabs 0 075mg Bpi(10544 257 30) Lannett(0527 1343 01) Rev2)
Packaging label for Levothyroxine Sodium Tablets USP 75 mcg (0.075 mg), containing 30 tablets. The label includes dosing instructions referring to the package insert, storage guidelines, and the NDC 10544-257-30. Manufactured by Blenheim Pharmacal, Inc., the label features barcodes, lot number BP00000000, and placeholder expiration dates.*
FDA Label Image

Structure (Levothyroxine Sodium Tablets Usp 1)

Structure (Levothyroxine Sodium Tablets Usp 1)
Chemical structure diagram of Levothyroxine Sodium illustrating the molecular arrangement including benzene rings, hydroxyl groups, and a sodium carboxylate moiety, consistent with the active ingredient Levothyroxine Sodium.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.